A. Biber

856 total citations
25 papers, 660 citations indexed

About

A. Biber is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, A. Biber has authored 25 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Complementary and alternative medicine and 7 papers in Pharmacology. Recurrent topics in A. Biber's work include Multiple Myeloma Research and Treatments (3 papers), Natural Compound Pharmacology Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). A. Biber is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Natural Compound Pharmacology Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). A. Biber collaborates with scholars based in Germany, Türkiye and Switzerland. A. Biber's co-authors include S. S. Chatterjee, Hartmut Fischer, E Koch, K. Hempel, C. Erdelmeier, G. Schmid, Holger F. Rabenau, Hans Wilhelm Doerr, Jaroslav Činátl and A.M. Brisson and has published in prestigious journals such as Blood, Experimental Brain Research and Toxicology Letters.

In The Last Decade

A. Biber

25 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Biber Germany 13 222 191 171 102 92 25 660
Saeed Niazmand Iran 16 230 1.0× 150 0.8× 157 0.9× 55 0.5× 131 1.4× 68 758
Nak‐Won Sohn South Korea 16 152 0.7× 61 0.3× 212 1.2× 143 1.4× 130 1.4× 52 629
Kuo‐Tong Liou Taiwan 17 141 0.6× 67 0.4× 271 1.6× 147 1.4× 116 1.3× 22 727
Kaishun Bi China 18 134 0.6× 140 0.7× 432 2.5× 114 1.1× 155 1.7× 31 814
Mousa‐Al‐Reza Hadjzadeh Iran 19 128 0.6× 129 0.7× 219 1.3× 72 0.7× 126 1.4× 42 852
Siamak Afshin‐Majd Iran 15 75 0.3× 115 0.6× 217 1.3× 115 1.1× 91 1.0× 33 744
F.K. Okwuasaba Nigeria 18 154 0.7× 213 1.1× 220 1.3× 42 0.4× 92 1.0× 41 827
Shu-Ying Chung Taiwan 10 138 0.6× 50 0.3× 165 1.0× 105 1.0× 31 0.3× 12 499
Nawab John Dar India 13 312 1.4× 69 0.4× 290 1.7× 111 1.1× 46 0.5× 29 868

Countries citing papers authored by A. Biber

Since Specialization
Citations

This map shows the geographic impact of A. Biber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Biber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Biber more than expected).

Fields of papers citing papers by A. Biber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Biber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Biber. The network helps show where A. Biber may publish in the future.

Co-authorship network of co-authors of A. Biber

This figure shows the co-authorship network connecting the top 25 collaborators of A. Biber. A scholar is included among the top collaborators of A. Biber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Biber. A. Biber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biber, A., et al.. (2023). Investigation of Antimicrobial Activities and 16S rRNA Sequences of Actinomycetes Isolated from Karst Caves in the Eastern Black Sea Region of Türkiye. Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi. 26(6). 1277–1290. 2 indexed citations
2.
Biber, A., et al.. (2018). In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma. TURKISH JOURNAL OF BIOLOGY. 42(5). 414–421. 14 indexed citations
3.
Ataş, Heval, et al.. (2017). Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line. Leukemia Research. 55. 33–40. 14 indexed citations
4.
Biber, A., et al.. (2009). Analytical characterisation of homoeopathic mother tinctures.. PubMed. 2009(1). 1–4. 7 indexed citations
6.
Biber, A., et al.. (2005). Quality criteria of homoeopathic mother tinctures: considerations regarding suitable tests for homoeopathic monographs.. PubMed. 2005(1). 53–9. 1 indexed citations
7.
Biber, A.. (2003). Pharmacokinetics of Ginkgo biloba Extracts. Pharmacopsychiatry. 36. 32–37. 54 indexed citations
8.
Kressmann, S., A. Biber, Meinolf Wonnemann, et al.. (2002). Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations. Journal of Pharmacy and Pharmacology. 54(11). 1507–1514. 49 indexed citations
9.
Biber, A., et al.. (2001). Stimulation of Glutamate, Aspartate and Gamma-Aminobutyric Acid Release from Synaptosomes by Hyperforin. Pharmacopsychiatry. 34(Suppl1). 11–19. 34 indexed citations
10.
Peeters, P. A. M., Jan Jaap van Lier, B. Oosterhuis, et al.. (1998). Pharmacokinetics of [14C]-labelled losigamone and enantiomers after oral administration to healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics. 23(1). 45–53. 9 indexed citations
11.
Biber, A., et al.. (1998). Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers. Pharmacopsychiatry. 31(S 1). 36–43. 158 indexed citations
12.
Langguth, Peter, et al.. (1996). Enzymatic Cleavage of Thymopoietin Oligopeptides by Pancreatic and Intestinal Brush-Border Enzymes. Peptides. 17(7). 1083–1089. 19 indexed citations
13.
Erdelmeier, C., Jaroslav Činátl, Holger F. Rabenau, et al.. (1996). Antiviral and Antiphlogistic Activities ofHamamelis virginianaBark. Planta Medica. 62(3). 241–245. 52 indexed citations
14.
Biber, A. & Angelika Dienel. (1996). Pharmacokinetics of losigamone, a new antiepileptic drug, in healthy male volunteers.. PubMed. 34(1). 6–11. 12 indexed citations
15.
Fourtillan, J. B., A.M. Brisson, J. Girault, et al.. (1995). [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].. PubMed. 50(2). 137–44. 64 indexed citations
16.
Schaffler, K., et al.. (1991). [Bioavailability of beta-aescin after oral administration of two preparations containing aesculus extract to healthy volunteers].. PubMed. 46(2). 145–145. 2 indexed citations
17.
Scherer, Gerhard, et al.. (1988). Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers.. PubMed. 66 Suppl 11. 5–11. 44 indexed citations
18.
Überla, K., et al.. (1987). Measuring problems in estimating the exposure to passive smoking using the excretion of cotinine. Toxicology Letters. 35(1). 35–44. 9 indexed citations
19.
Biber, A., G. Schmid, & K. Hempel. (1984). Calmodulin content in specific brain areas. Experimental Brain Research. 56(2). 323–6. 29 indexed citations
20.
Biber, A. & K. Hempel. (1984). Radioimmunoassay of Oxidized Calmodulin in Chloramine-T Treated Tissue Samples. Clinical Chemistry and Laboratory Medicine (CCLM). 22(2). 185–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026